Global Advanced Therapy Medicinal Products Market, By Therapy Type (CAR-T Therapy, Cell Therapy, Tissue Engineered Product, Gene Therapy, Others), Product Type (Tissue Engineered Products, Somatic Cell Treatment Product, Joined ATMPs, Others), Applications (Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Advanced Therapy Medicinal Products Market
Advanced therapy medicinal products market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 13.20% in the above mentioned forecast period.
Advanced therapy medicinal products (ATMPs) are the medicines for the human use with an active therapeutic substance and are produced through the biological processes. These are the revolutionary treatments which depend on the substantial cell treatment, quality treatment and tissue constructed items. These innovative therapies include gene therapy, cell therapy and tissue engineered products. Advanced therapy medicinal products exhibit the potential to cure diseases by addressing their root cause rather than symptomatic treatment. Hence, ATMPs delivers the transformative advantages which are not offered by the conventional treatment. These are the driving factors that will accelerate the market growth.
Rise in the prevalence of Alzheimer ’s disease, growing healthcare expenditure, upsurge in the use of advanced therapy medicinal products for the treatment of life-threatening diseases, growing government funding are the factors that will expand the advanced therapy medicinal products market. Furthermore, growing demand for gene therapies coupled with technological advancement in genetic engineering tool for instance RNAi are the factors that will escalate the market growth.
Trends advanced therapy medicinal products development and rise in the development of highly potent, targeted products for the treatment of chronic disorders such as cancer, lung cancer and others will provide beneficial opportunities for the advanced therapy medicinal products market in the forecast period of 2021-2028.
However, lack of funds, inadequate transparency and regulatory guidance for biopharmaceutical companies to manufacture these products and therapies are the factors that will hinder the market growth and will further challenge the advanced therapy medicinal products market in the forecast period mentioned above.
This advanced therapy medicinal products market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the advanced therapy medicinal products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Advanced Therapy Medicinal Products Market Scope and Market Size
The advanced therapy medicinal products market is segmented on the basis of therapy type, product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of therapy type, the advanced therapy medicinal products market is segmented into CAR-T therapy, cell therapy, tissue engineered product, gene therapy and others. Cell therapy has been further sub-segmented into stem cell therapy and non-stem cell therapy.
- On the basis of product type, the advanced therapy medicinal products market is segmented into tissue engineered products, somatic cell treatment product, joined ATMPs and others.
- On the basis of application, the advanced therapy medicinal products market is segmented into muscular dystrophies, alzheimer’s, hemophilia, cystic fibrosis and others.
- On the basis of end-users, the advanced therapy medicinal products market is segmented into clinic, hospital and others.
The advanced therapy medicinal products market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Advanced Therapy Medicinal Products Market Country Level Analysis
Advanced therapy medicinal products market is analyzed and market size information is provided by the country, therapy type, product type, application, end-users and distribution channel as referenced above.
The countries covered in the advanced therapy medicinal products market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the advanced therapy medicinal products market due to the presence of major key players, extensive R&D spending, favourable regulations, successful drugs, high healthcare expenditure and development in the field of gene and cell therapy in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing number of skin burn cases and cancer diseases.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Advanced therapy medicinal products market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Advanced Therapy Medicinal Products Market Share Analysis
Advanced therapy medicinal products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to advanced therapy medicinal products market research.
The major players covered in the advanced therapy medicinal products market report are uniQure N.V., Pfizer Inc., bluebird bio, Inc., BioMarin, Novartis AG, GENERAL ELECTRIC COMPANY, Takeda Pharmaceutical Company Limited, Gilead Sciences, Inc., Spark Therapeutics, Inc., CELGENE CORPORATION, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., MEDIPOST, VERICEL CORPORATION, PHARMICELL Co., Ltd., Organogenesis Inc., Abeona Therapeutics Inc., Humacyte, Inc., and Bristol-Myers Squibb Company, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-